although the etiology remains unknown , the spectrum of shml has been expanded to include predominance of extranodal disease in some patients , clinically significant immunologic abnormalities in 10 % of patients , and fatal outcome in 7 % of patients .
C0019625
shml
C1517068
extranodal disease